Cargando…
A 6-week, multicentre, randomized controlled clinical trial to evaluate the safety and efficacy of placeboxetine hydrochloride in the treatment of major depressive disorder in an Indian setting
INTRODUCTION: This paper describes a fictitious study of a fictitious drug. A companion paper in this issue of the Indian J Psychiatry critically examines this paper and provides author, reader, reviewer, and researcher perspectives on problems related to the design and conduct of a clinical trial;...
Autor principal: | Andrade, Chittaranjan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3056193/ https://www.ncbi.nlm.nih.gov/pubmed/21431013 http://dx.doi.org/10.4103/0019-5545.75555 |
Ejemplares similares
-
Placeboxetine for major depressive disorder: Researcher, author, reader, and reviewer perspectives on randomized controlled trials
por: Andrade, Chittaranjan
Publicado: (2011) -
How to write a good abstract for a scientific paper or conference presentation
por: Andrade, Chittaranjan
Publicado: (2011) -
Report on the EURISOL Design Study Week
por: Blumenfeld, Yorick
Publicado: (25/0) -
EURISOL MERCURY TARGET EXPERIMENT: CERN SAFETY REPORT
por: J. Gulley (CERN SC/GS)
Publicado: (15/1) -
COVAL Nancy – Étude de séroprévalence contre le virus SARS-CoV-2 (COVID-19) dans la population de la Métropole du Grand Nancy
por: Legrand, K., et al.
Publicado: (2021)